Moreover, we performed RNA-seq on bone marrow CD34+ cells from 2 patients with MDS with the U2AF1S34F mutation, 4 patients with MDS without known mutations in splicing factor genes, and 5 healthy controls. This evidence concerns the gene CD34 and myelodysplastic syndrome.